The role of NKT cells in tumor immunityScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsTherapeutic Lymphoid Organogenesis in the Tumor MicroenvironmentMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentAEG-1/MTDH/LYRIC in liver cancerATP-dependent chromatin remodeling complexes as novel targets for cancer therapyTherapeutic cancer vaccines: past, present, and futureRole of oxidative stress and the microenvironment in breast cancer development and progressionAEG-1/MTDH/LYRIC: clinical significanceAntitumor immunity at work in a melanoma patientATM: genome stability, neuronal development, and cancer cross pathsThe life and death of a B cellThe von Hippel-Lindau tumor suppressor complex and regulation of hypoxia-inducible transcriptionThe Abl family kinases: mechanisms of regulation and signalingAdvances in chemotherapy of cancer in manMutations predisposing to hereditary nonpolyposis colorectal cancerjun: oncogene and transcription factor5-methylcytosine, gene regulation, and cancerUnravelling the Complexity and Functions of MTA Coregulators in Human CancerStructural and functional diversity in the FGF receptor multigene familyPhagocytes as Corrupted Policemen in Cancer-Related InflammationPAKs in Human Cancer Progression: From Inception to Cancer Therapeutic to Future OncobiologyPharmacodynamic biomarkers for molecular cancer therapeuticsProstate cancer and the met hepatocyte growth factor receptorKeratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repairRaf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosisGenetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancerThe ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancerPI3K/PTEN signaling in angiogenesis and tumorigenesisThe Ah locus and the metabolism of chemical carcinogens and other foreign compoundsPhosphoinositide 4- and 5-kinases and the cellular roles of phosphatidylinositol 4,5-bisphosphateAEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expressionMutations Predisposing to Hereditary Nonpolyposis Colorectal CancerThe Abl family kinases: Mechanisms of regulation and signalingSH2 and SH3 domains in signal transduction.c-Src, receptor tyrosine kinases, and human cancer.Molecular imaging of the tumor microenvironment for precision medicine and theranostics.Role and regulation of human tumor suppressor SUFU in Hedgehog signaling.
P1433
Q24648939-FA9722B2-0B11-46D0-A98E-154624791726Q26799114-E679F7CC-55D6-4BA5-BD13-EFD262AAE5F9Q26799117-3BAD4201-4B11-4D5A-AE05-B31E8241A048Q26799120-AEC674C6-BD85-4277-BC1A-AC7251E2C1A6Q26799123-E0DA806A-BEF8-461C-9D48-824B143C81E8Q26799126-0E352AF0-E7B1-4209-9962-51141D113F14Q26822570-9262C032-B9B8-4D59-8013-12C45836FAFFQ26849467-F73C7A32-615F-47C5-93C1-AB4BF0F93E91Q26863283-543B4CC1-F400-4680-89D7-738ECDBE23DBQ27003859-165AD9E0-3411-467E-9B95-285AAC34090EQ27014932-7A38DC03-3867-4083-96EF-CEEAC6475FDFQ28142431-1E396E49-358B-4CE3-9F68-35664D236934Q28201456-E67B4203-DE31-474D-8404-B45F14B87191Q28206532-7719358D-417E-4E94-AD6F-4C1C4E396DC3Q28206541-E68F6CBC-B0EA-410B-9F3A-177974DFE767Q28206550-36E05211-CCE2-485D-B075-0C9C7161A7F4Q28213539-DA623582-86CE-4CE0-A239-C63A5C73CD34Q28235642-6E0F04B7-E8B4-4169-B077-0DC283F93CD6Q28240588-0ECBF3F3-1F76-45C3-953A-6D2FEFB22EF9Q28262788-CC03D6BC-1F19-46F5-90AD-AE6587A7AC95Q28263781-D30D479A-6F00-4541-8A5A-27DFD218B226Q28265126-F2412277-5D75-4349-B917-43286EA263CEQ28265626-D07C86D7-B98C-40A5-AB9F-50B43539425BQ28274522-BE9DC555-3FD8-496E-93C8-609EEF985B61Q28278381-1D854534-0382-41E6-9FA3-AED49DC45CAAQ28278555-691CB16E-C5B1-4315-BC6C-EEB726814E63Q28278567-2063B2FE-BA04-4C48-A514-777167947A3AQ28278590-788E1335-9CCE-4DDE-9A58-7A654288C1C0Q28285050-0DB42A06-AD6D-46C5-85E1-CF4D3774B579Q28297155-8F9B2C1C-B1E1-4405-977E-0380ADCAE816Q28383083-4740F4AD-D2B4-4D95-BE00-04EC02FFE74EQ28512468-EBF542CA-3311-4183-8A72-A2064EE48492Q28609603-D39F11A0-BA99-4803-A815-FF0FBD40352DQ28658809-41BF5342-C916-4ECB-9B03-765EA732C695Q29014079-0EA78EF0-1718-44C2-A989-B6A4CB605B4DQ29307816-ED430353-94D2-454D-BA9B-2F89946E4B78Q30194618-99984B0E-F374-4152-AD78-B72D3F7C3382Q30303932-1567BA0C-3FB4-4D21-B3F0-838EE54E154EQ30367515-852FF066-B062-421C-A67D-5204BC23C310Q30373722-DC9923DF-E2C6-491B-925C-4EA97F87E486
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
periodiek van uitgeverij Elsevier
@nl
name
Advances in Cancer Research
@da
Advances in Cancer Research
@de
Advances in Cancer Research
@en
Advances in Cancer Research
@fi
Advances in Cancer Research
@fr
Advances in Cancer Research
@nb
Advances in Cancer Research
@nl
Advances in Cancer Research
@nn
Advances in Cancer Research
@sv
type
label
Advances in Cancer Research
@da
Advances in Cancer Research
@de
Advances in Cancer Research
@en
Advances in Cancer Research
@fi
Advances in Cancer Research
@fr
Advances in Cancer Research
@nb
Advances in Cancer Research
@nl
Advances in Cancer Research
@nn
Advances in Cancer Research
@sv
prefLabel
Advances in Cancer Research
@da
Advances in Cancer Research
@de
Advances in Cancer Research
@en
Advances in Cancer Research
@fi
Advances in Cancer Research
@fr
Advances in Cancer Research
@nb
Advances in Cancer Research
@nl
Advances in Cancer Research
@nn
Advances in Cancer Research
@sv
P1055
P1058
P1156
P123
P1476
Advances in Cancer Research
@und
P236
P31
P407
P571
1953-01-01T00:00:00Z